Hyperlipidemia Flashcards

1
Q

What are the different types of lipids and what do they do?

A

Cholesterol: helps form steroid hormones & bile acids
Triglycerides: helps transfer energy from food to cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How are lipids transported? How are they classified by density?

A
  • Lipoproteins, which contain proteins called apoproteins
  • Low density = more triglycerides
  • High density = more apoproteins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the 5 major groups of Lipoproteins based on density from largest to smallest?

A

Bad or Non-HDL: Chylomicron and Chylomicron remnant, very low density lipoprotein (VLDL), intermediate density lipoprotein (IDL), low density lipoprotein (LDL)
Good: high density lipoprotein (HDL)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is hyperlipidemia? List 2 other names for it.

A

HLD: elevation of both total cholesterol and triglycerides

-dyslipidemia & dyslipoproteinemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe the transport of lipids.

A
  1. Liver uses fat and cholesterol stores to make VLDL.
  2. VLDL transfers TG to cells
  3. LDL is created as it looses TG
  4. LDL provides cholesterol to cells
  5. Excess LDL taken up by the liver, helps trigger formation of plaque
  6. HDL made in liver and intestine will work against process by removing excess cholesterol from blood and tissue cells
  7. HDL gives VLDL back some of this cholesterol, which turns it back to LDL
  8. liver removes LDL from bloodstream & converts its cholesterol to bile acid
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are 4 examples of cardiovascular diseases?

A
  • Coronary heart dz (CHD)
  • Peripheral artery dz. (PAD)
  • Aortic atherosclerosis & thoracic or AAA
  • Cerebrovascular dz
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the difference between primary and secondary prevention of CVD?

A

primary: pt has no evidence of ASCVD
secondary: goal is the prevention of a 2nd event

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the difference between primary and secondary dyslipidemia?

A

Primary: genetic abnormality of cholesterol metabolism
Secondary: DM, ETOH use, hypothyroidism, cholestatic liver dz, renal dz, smoking, obesity, medications (OCPs, thiazide diuretics, BetaBlockers, atypical antipsychotics, protease inhibitors)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How is cholesterol carried?

A

Total cholesterol = HDL + VLDL + LDL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Most clinical labs measure…? How do they calculate VLDL Cholesterol?

A
  • total cholesterol, triglycerides, and HDL

- VLDL cholesterol = Triglycerides / 5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How do you ensure the pt gives the lowest TG level? Why is this important?

A
  • MUST be fasting

- if TG is elevated over 200mg/dL the estimation of LDL will be way off

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is ASCVD? How is it started and how is it enhanced?

A
  • when fatty material collects in arterial walls, hardening over time
  • started by excess cholesterol (VLDL & LDL): genetic, insulin resistant, organ dysfunction
  • enhanced by lifestyle: saturated fats/trans-fats, obesity, smoking, BP
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe the process of plaque formation.

A
  • small/dense LDL enters and sticks to artery wall
  • triggers cascade of events: 1) oxidation of LDL -proinflammatory, thrombotic 2) attracts macrophages - foam cells
    3) endothelial dysfunction 4) vasoconstriction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What happens if a plaque ruptures in the bloodstream?

A
  • MI in coronaries
  • TIA or CVA in the brain
    Note: pt doesn’t feel pain until plaque ruptures so often goes undetected
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Give examples of non-modifiable and modifiable cardiovascular risk factors

A

Non: age (M >45yo & F >55yo), sex, family hx of premature heart dz in 1st degree relative (M >55yo & F >65yo)
Mod: dyslipidemia, kidney dz, obesity, HDL, HTN, DM, diet, smoking

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What percent of the pt population have CVD diagnoses and CVD deaths under the age of 65 y/o?

A
dx = 50%
deaths = 15%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Compare and contrast Framingham and ACC/AHA CVD risk scores.

A
  • Fram: 10yr risk for MI or death
  • A/A: 10yr risk for heart dz or CVA, race (AA/other), DBP, DM
  • Both: total & HDL cholesterol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is the relationship between lipids & CVD risk?

A
  • inc. LDL = inc ASCVD risk
  • inc. HDL = dec ASCVD risk
  • primary prevention –> moderate benefits
  • secondary prevention –> strong data
  • for each 1% reduction in LDL –> 1-1.5% reduction in risk of major cardiovasc. events. (even treating mild elevated LDL is beneficial)
  • for each 2-3% increase in HDL –> 2-4% reduction in risk of major cardiovasc events
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

List some examples of secondary causes associated with lipid abnormality.

A
  • obesity, sedentary lifestyle, DM, ETOH use, nephrotic syndrome, hypo/hyperthyroid, Cushing, diuretics, BBs meds
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What are some characteristic PE findings for evidence of CVD or 2ndary causes of HLD

A
VS: waist circumference
Skin: xanthomatous tendons, eruptive xanthomas
HEENT: lipemia retinalis, corneal arcus
Heart: PMI? extra sounds
Abdomen: hepatomegaly, kidney masses
Extremities: foot exam (DM), PAD?, edema
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

NCEPP ATP III guidelines

A

Steps:

1) determine lipoprotein levels after 9-12 hr fast
2) identify clinical atherosclerotic dz that results in H risk for CHD
3) determine risk factors other than LDL
4) if 2+ risk factors present w/out CHD or risk eq. –> asses 10yr w/ Framingham’s
5) Determine risk category
6) start TLC (therapeutic lifestyle changes) if LDL is above goal
7) consider adding drug therapy if it remains above goal
8) identify metabolic syndrome and treat if 3 mo of TLC not working
9) treat elevated triglycerides and low HDL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is an optimal LDL level for a patient with CAD? optimal HDL?

A
  • LDL = < 70mg/dL but otherwise 100

- HDL = <40 M or <50 F

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is step 2 in the ATP III guidelines for hyperlipidemia?

A
Identify presence of clinical atherosclerotic disease that confers high risk for CHD events (CHD risk equivalent)
CAD
PAD
AAA
DM
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What are the major risk factors in Step 3 ATP III guidelines?

A
  • smoking
  • HTN
  • HDL < 40mg/dL
  • family hx of premature coronary dz
  • men > 45 and women >55 yrs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What is the 4th step in the ATP III guidelines?

A

if 2+ factors present w/out CHD or risk eq., asses 10 yr CHD risk (Framingham)

  • > 20% CHD risk eq.
  • 10-20%
  • <10%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What is the 5th step in the ATP III guidelines?

A

determine risk category.
- CHD or risk eq w/ 10yr >20%: treat LDL down to <100 or (<70 optional); >100 start TLC; if >130 then drug therapy

  • 2+ risk factors w/ 10yr <20%: treat LDL down to <130; if >130 then TLC but if 10-20% CHD risk then drug; if less than 10% CHD risk then >160 drug therapy
  • 0-1 Risk factor: <160 LDL goal; >160 TLC; >190 drug
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What is step 6 of ATP III guidelines?

A
Initiate TLC if LDL is above goal.
TLC:
- AHA low fat diet
- dietary cholesterol intake <200 mg/day
- increased viscous fiber
- add plant stanols/sterols
- maximize TLC can reduce LDL 25-30%
- aggressive weight management
- exercise 30 mins/day
28
Q

What is step 7 of the ATP III guidelines?

A

consider adding drug therapy if LDL remains above goal if LDL still high after 3mo’s TLC

29
Q

What is step 8 of the ATP III guidelines for hyperlipidemia?

A

identify metabolic syndrome and treat, after 3 mo’s TLC.
Metabolic syndrome RF (3 or more):
- abdominal obesity (waist circumference)
- Triglycerides
- low HDL
- incr BP
- impaired fasting glucose

30
Q

What is step 9 of the ATP III guidelines for hyperlipidemia?

A

treat elevated triglycerides & low HDL; if >200 maximize statin therapy and consider non-statin Rx

  • first reach LDL level
  • intensive TLC to incr HDL (incr. monounsaturated fats)
31
Q

ACC/AHA 2013 guidelines for hyperlipidemia. Who gets screened? Target goal for TC and LDL?

A
  • screen: all adults 21+ y/o; repeat every 5 yrs for avg/low risk; repeat more frequently if close to therapeutic thresholds
  • No specific #, instead focus on dose of med and lowering LDL
32
Q

What are the 4 major groups of people who should be treated w/ statins?

A

1) anyone w/ ASCVD
2) any adult w/extremely elevated LDL (>190mg/dL)
3) 40-75 yo’s w/ DM w/LDL 70-189mg/dL
4) 40-75 yo’s w/ 10yr risk >/= to 7.5% per new risk calculator

33
Q

Who is recommended to get “high” intensity treatment for HLD according to the ACC/AHA 2013 guidelines?

A
  • anyone w/ ASCVD up to age 75
  • any adult w/extremely elevated LDL (>190 mg/dL)
  • treatment reduces LDL by ~50%
34
Q

Which drugs/doses are recommended for “high” intensity treatment for HLD according to the ACC/AHA 2013 guidelines?

A
  • Atorvastatin 40 or 80mg

- Rosuvastatin 20mg or 40mg

35
Q

Who is recommended to get “moderate” intensity treatment for HLD according to the ACC/AHA 2013 guidelines?

A
  • 40-75 yo’s, LDL 70-189 mg/dL (…if 10 yr risk >7.5%, consider “high” intensity)
  • treatment reduces LDL by 30-50%
36
Q

Which drugs/doses are recommended for “moderate” intensity treatment for HLD according to the ACC/AHA 2013 guidelines?

A

Atorvastatin 10-20mg
Simvastatin 20-40mg
Pravastatin 40mg

37
Q

What intensity statin would you give for 40-75 yo’s w/ LDL >70 mg/dL w/ a 10yr risk >7.5% per risk calculator?

A

strong evidence for Moderate or High

38
Q

What is the approach to implementing Therapeutic Lifestyle Changes?

A
  • Start
  • Encourage…pt to make 1 diet and 1 exercise goal
  • Follow-up: 4 wk f/u reduces LDL by 5-10%
  • also use handouts/aids/resources to teach lables, portion size, eating out
39
Q

Describe TLC diet recommendations.

A
  • AHA low fat diet
  • Mediterranean: replaces sat fats w/ monsat fats (olives, peanuts, avocados), lowers LDL while sparing reduction in HDL
  • plant stanols/sterols (can reduce LDL by 10%)
  • Vitamin C, antioxidants
  • all combined can lower LDL by up to 30%
40
Q

What is the pharmacologic treatment for hyperlipidemia according to ACC/AHA guidelines?

A

STATINS!

-not other meds & not combo therapy

41
Q

STATINS or HMG-CoA reductase inhibitors: what is the MOA? When to dose?

A
  • inhibit the rate-limiting enzyme in the formation of cholesterol
  • at night when CHO is synthesized
42
Q

List some examples of STATINS or HMG-CoA reductase inhibitors.

A
Rosuvastatin
Atorvastatin
Simvastatin
Pravastatin
Fluvastatin
Pitavastatin
43
Q

What are HMG-CoA reductase inhibitors, or statins, effects on lipids?

A
  • *LDL decreases 20-55+%
  • HDL increase 5-15%
  • TG decrease 7-30%
44
Q

What are contraindications for using statins or HMG-CoA reductase inhibitors?

A
  • Pregnancy & breastfeeding
  • active liver dz
  • unexplained elevated LFT’s
45
Q

What are major side effects for using statins or HMG-CoA reductase inhibitors?

A
  • myalgia
  • myopathy, rhabdomyolysis
  • hepatotoxicity
  • increased DM risk
46
Q

What follow-up labs should you check if using statins or HMG-CoA reductase inhibitors?

A
  • LFTs

- Creatine kinase: baseline; if myalgias present

47
Q

Cholesterol absorption inhibitor: MOA? lipid effects? Contraindications? Example?

A
  • decreases absorption of cholesterol in small intestine & upregulates LDL receptors on peripheral cells
  • LDL decrease by 15-20%
  • Contraindications: caution w/hepatic impairment; do NOT use w/fibrates
  • i.e. Ezetimibe
48
Q

Fibric acid derivatives: MOA? When to give? Examples?

A
  • reduced synthesis and increased breakdown of VLDL particles
  • Drug of choice if TG >500 on initial presentation
  • Fenofibrate, Gemfibrozil
49
Q

Fibric acid derivatives: effects on lipids?

A
  • LDL decrease 10-15%
  • HDL increase 15-20%
  • *TG decrease 40%
50
Q

Fibric acid derivatives: side effects?

A
  • cholelithiasis
  • Hepatitis
  • Myositis
51
Q

Fibric acid derivatives: contraindications?

A
  • active liver dz or permanent impairment
  • gallbladder dz
  • caution w/ pregnancy and renal impairment
  • *Not recommended w/ Statin use
52
Q

Niacin (nicotinic acid or Vitamin B3): MOA? examples?

A

reduces the production of VLDL particles

  • Note: available in short acting (OTC) and long acting (Rx) but Rx is better tolerated
  • i.e. Niacin, Niaspan, Slo-Niacin
53
Q

Niacin (nicotinic acid or Vitamin B3): Lipid effects? side effects?

A
  • LDL decreases 15-25%
  • HDL increases 25-35%
  • TGs decrease by up to 50%
  • best for moderately high LDL and very low HDL
  • Side effects: flushing
54
Q

Niacin (nicotinic acid or Vitamin B3): contraindications?

A
  • pregnancy & breastfeeding
  • active liver dz
  • active peptic ulcer
  • caution w/ gout & DM
55
Q

Bile-acid binding resins: MOA? examples?

A
  • bind bile acids in the intestine: liver will increase its production, using hepatic cholesterol to do so
  • i.e. cholestyramine, colesevelam, colestipol
    Note: only lipid-lower medication considered safe in pregnancy
56
Q

Bile-acid binding resins: lipid effects? side effects?

A
  • LDL decreased 15-25%
  • HDL - no effect
  • TG - little effect or may increase
  • side effects: GI sxs
57
Q

Bile-acid binding resins: when to prescribe?

A
  • In patients w/ moderate increased LDL & normal HDL/TG OR high risk pregnant women
58
Q

Bile-acid binding resins: contraindications?

A
  • current or h/o GI obstruction
  • hypertriglyceridemia
  • pancreatitis
59
Q

PCSK9 Inhibitors: MOA? Lipid effect? Frequency? Why give? examples?

A
  • monoclonal antibodies
  • blocks PCSK9 effect of degrading LDL receptors
  • lowers LDL by 50-60%
  • administer by SC injection q 2-4wks
  • alternative for non-tolerance of statins
  • i.e Alirocumab, Evolocumab
60
Q

What benefits do Omega-3 fatty acids have?

A
  • improve TG, lower CV risk

- anti-inflammatory

61
Q

What is Familial hypercholesterolemia?

A
  • genetic disorder in which LDL receptors absent or dysfunctional
  • homozygotes: LDL 8x normal
  • heterozygotes: LDL 2x normal
62
Q

What is Familial hyperchylomicronemia?

A
  • genetic disorder w/ Lipoprotein lipase abnormality
  • enzyme that allows peripheral tissue to take up TG from chylomicrons and VLDL
  • severe hypertriglyceridemia
63
Q

How are triglycerides transported?

A

through blood w/in lipoproteins into skeletal muscle and adipose tissue to use as energy

64
Q

How do you know if a pt has metabolic syndrome?

A

pt must have 3 of the following:

  • central obesity
  • High BP
  • high TG (fats)
  • low HDL cholesterol
  • insulin resistance
65
Q

What lab values make up mild, moderate, and severe hypertriglyceridemia?

A

Mild: 200-499 mg/dL
Mod: >500 mg/dL
Severe: >1000 mg/dL, acute pancreatitis